Cargando…
GPEdit: the genetic and pharmacogenomic landscape of A-to-I RNA editing in cancers
Altered A-to-I RNA editing has been widely observed in many human cancers and some editing sites are associated with drug sensitivity, implicating its therapeutic potential. Increasing evidence has demonstrated that a quantitative trait loci mapping approach is effective to understanding the genetic...
Autores principales: | Ruan, Hang, Li, Qiang, Liu, Yuan, Liu, Yaoming, Lussier, Charles, Diao, Lixia, Han, Leng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728115/ https://www.ncbi.nlm.nih.gov/pubmed/34534336 http://dx.doi.org/10.1093/nar/gkab810 |
Ejemplares similares
-
LNCediting: a database for functional effects of RNA editing in lncRNAs
por: Gong, Jing, et al.
Publicado: (2017) -
HeRA: an atlas of enhancer RNAs across human tissues
por: Zhang, Zhao, et al.
Publicado: (2020) -
The genetic and pharmacogenomic landscape of snoRNAs in human cancer
por: Liu, Yaoming, et al.
Publicado: (2020) -
APAatlas: decoding alternative polyadenylation across human tissues
por: Hong, Wei, et al.
Publicado: (2020) -
Pancan-meQTL: a database to systematically evaluate the effects of genetic variants on methylation in human cancer
por: Gong, Jing, et al.
Publicado: (2019)